Jobs
Bluebird Bio

Bluebird Bio
Develops gene therapies for severe genetic disorders.
Gene Therapy
Biotechnology
Clinical Research
Genetic Engineering
Cell Biology
Open Positions
0 positions
No open positions at this time
Products & Services
ZY
Zynteglo
Gene Therapy
SK
Skysona
Gene Therapy
LE
Lenti-D
Gene Therapy Research
BB
bb2121 (ide-cel)
CAR-T Cell Therapy
BB
bb21217
CAR-T Cell Therapy
GE
Gene Therapy Manufacturing Services
Manufacturing Services
Similar Companies

Eli Lilly
Public
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
10,001+
902 open jobs

HCA Healthcare
Public
Leading company in the healthcare industry
Nashville, Tennessee, United States
10,001+

Vir Biotechnology
Public
Immunology-focused biotech
San Francisco, California, United States
201-500
Valuation $1.2B
8 open jobs

Editas Medicine
Public
Genome editing company
Cambridge, Massachusetts, United States
201-500

Sarepta
Public
Genetic medicine company
Cambridge, Massachusetts
501-1,000

Edwards Lifesciences
Public
Medical devices for heart disease
Irvine, California, United States
10,001+
News & Buzz
All
X
News
HN
YouTube
bluebird bio sees higher offer for company from Ayrmid Pharma - MSN
Source: MSN
google-news
·
1mo ago
Bye Bye Bluebird: Gene Therapy Biotech Emerges From Private Buyout With Rebrand - BioSpace
Source: BioSpace
google-news
·
5mo ago
Bluebird bio flies to pastures new with Genetix rebranding - Pharmaceutical Technology
Source: Pharmaceutical Technology
google-news
·
5mo ago
After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics - Fierce Pharma
Source: Fierce Pharma
google-news
·
5mo ago
bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots - Business Wire
Source: Business Wire
google-news
·
5mo ago
More (5 remaining)
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Reviews
3.1
4 reviews
Work Life Balance
3.0
Compensation
2.5
Culture
2.5
Career
2.8
Management
2.2
25%
Recommend to a Friend
Pros
FDA approval for gene therapy treatments
Strong product launches (ZYNTEGLO and SKYSONA)
Positive earnings performance
Cons
Significant stock price volatility and shareholder value loss
Black box warning requiring long-term cancer monitoring
Financial challenges and uncertainty
Salary Ranges
200 data points
Junior/L3
Mid/L4
Senior/L5
Junior/L3
2 reports
$94,657
total / year
Base
$72,907
Stock
-
$94,067
$95,278
Interview Experience
2 interviews
Difficulty
2.5
/ 5
Duration
2-5w
Offer Rate
50%
Experience
Positive 50%
Neutral 50%
Negative 0%
Interview Process
1
Application Review
2
Recruiter Screen
3
Hiring Manager Interview
4
Panel Interview
5
Offer
Contact & Location